Compare Hormel Foods Corp (HRL) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hormel Foods Corp vs Tempus AI — how do they compare? Hormel Foods Corp trades at $19.44 (market cap $10.76B), while Tempus AI trades at $69.99 (market cap $12.77B). The key difference: Tempus AI is the larger of the two by market cap, and Hormel Foods Corp pays a 5.98% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hormel Foods Corp for 99 Days and Tempus AI for 22 Days on average.
| HRL | TEM | |
|---|---|---|
Market Cap | $10.76B | $12.77B |
Volume | 6,064,955 | 8,980,490 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $26.50 | $99.28 |
52-Week Low | $19.42 | $41.55 |
Typical Hold Time | 99 Days | 22 Days |
Enterprise Value | $12.75B | $13.40B |
Dividend Yield | 5.98% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hormel Foods (HRL) trades at $19.42, down 2.31% with bearish technical signals. The stock shows mixed fundamentals with a P/E of 31.53 and net margin of 2.82%, while recent earnings beat expectations. The company maintains a 60-year dividend streak but faces margin pressure. Recent $1.06B Brakebush acquisition aims to expand foodservice chicken business, representing significant strategic investment.
Outlook remains cautious with analyst consensus at Hold (57%) and $24.25 price target suggesting 25% upside. Key risks include shrinking dividend raises, margin compression, and integration challenges from recent acquisition. The dividend yield of approximately 3% provides income support, but growth concerns persist amid inflationary pressures.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
